What is Fluoresprobe Sciences?
Fluoresprobe Sciences LLC is at the forefront of developing advanced fluorescent assays, with a particular focus on the precise measurement of unbound bilirubin levels in serum. The company is dedicated to enhancing, standardizing, and validating methodologies for bilirubin quantification, addressing a critical need for reliable and accessible techniques within the medical community. Their innovative products are designed for adoption by healthcare professionals and researchers engaged in medical diagnostics and clinical studies. The company's current phase suggests a strong market validation and a push towards broader commercialization of its specialized diagnostic tools.
How much funding has Fluoresprobe Sciences raised?
Fluoresprobe Sciences has raised a total of $164K across 1 funding round:
Debt
$164K
Debt (2021): $164K with participation from PPP
Key Investors in Fluoresprobe Sciences
PPP
Public-Private Partnership
What's next for Fluoresprobe Sciences?
With the recent major strategic investment, Fluoresprobe Sciences is poised to significantly scale its operations and further refine its product offerings. The substantial capital infusion, characteristic of large-scale late-stage funding, indicates investor confidence in the company's technology and market potential. Future endeavors will likely concentrate on expanding the reach of their bilirubin measurement assays, potentially exploring new applications or enhancing existing product lines. Strategic partnerships and further research and development are anticipated as the company solidifies its position in the medical diagnostics landscape.
See full Fluoresprobe Sciences company page
